Vitamin D status and insulin requirements in children and adolescent with type 1 diabetes

Journal of Pediatric Endocrinology and Metabolism

Volumn 24, Issue 11-12, 2011, Pages 1037-1041

  Tunc, Ozgul ^a   Cetinkaya, Semra ^b   Kízílgün, Murat ^a   Aycan, Zehra ^b  

^a Ankara Di kapi Children's Health and Dis Hematology Onc Training and Res Hospital   (Turkey)

^b Dr Sami Ulus Obstetrics and Gynecology   (Turkey)

Author keywords

insulin sensitivity; type 1 diabetes; vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; ALKALINE PHOSPHATASE; CALCITRIOL; CALCIUM; INSULIN; INSULIN ASPART; INSULIN GLARGINE; INSULIN LISPRO; PARATHYROID HORMONE; PHOSPHORUS; VITAMIN D;

ADOLESCENT; ADULT; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; BLOOD SAMPLING; CALCIUM BLOOD LEVEL; CHILD; CONTROLLED STUDY; DIAGNOSTIC TEST; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; DISEASE DURATION; DRUG EFFICACY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN SENSITIVITY; INSULIN TREATMENT; MAJOR CLINICAL STUDY; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; PRESCHOOL CHILD; SCHOOL CHILD; SCREENING TEST; SENSITIVITY AND SPECIFICITY; TREATMENT DURATION; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION;

ADOLESCENT; BIOLOGICAL MARKERS; CALCITRIOL; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 1; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; LOGISTIC MODELS; VITAMIN D; VITAMIN D DEFICIENCY; YOUNG ADULT;

EID: 83655190894     PISSN: 0334018X     EISSN: 21910251     Source Type: Journal    
DOI: 10.1515/JPEM.2011.213     Document Type: Article

References (27)

1. Wagner CL, Taylor SN, Hollis B. Does vitamin D make the world go 'round'? Breastfeed Med 2008;3:239-50.
2. Mauricio D, Mandrup-Poulsen T, Nerup J. Vitamin D analogues in insulin-dependent diabetes mellitus and other autoimmune diseases: a therapeutic perspective. Diabetes Metab Rev 1996;12:57-68. (Pubitemid 26164839)
3. Bourlon PM, Billaudel B, Faure-Dussert A. Infl uence of vitamin D3 defi ciency and 1,25 dihydroxyvitamin D3 on de novo insulin biosynthesis in the islets of the rat endocrine pancreas. J Endocrinol 1999;160:87-95. (Pubitemid 29044571)
4. Baynes KC, Boucher BJ, Feskens EJ, Kromhout D. Vitamin D, glucose tolerance and insulinaemia in elderly men. Diabetologia 1997;40:344-7. (Pubitemid 27096561)
5. Holick MF. Diabetes and the vitamin D connection. Curr Diab Rep 2008;8:393-8.
6. Danescu LG, Levy S, Levy J. Vitamin D and diabetes mellitus. Endocrine 2009;35:11-7.
7. Mathieu C, Badenhoop K. Vitamin D and type 1 diabetes mel-litus: state of the art. Trends Endocrinol Metab 2005;16:261-6. (Pubitemid 41058757)
8. Malabanan A, Veronikis IE, Holick MF. Redefi ning vitamin D insufficiency. Lancet 1998;351:805-6.
9. Bowden AS, Robinson RF, Carr R, Mahan JD. Prevalence of vitamin D defi ciency and insuffi ciency in children with osteope-nia or osteoporosis referred to a pediatric metabolic bone clinic. Pediatrics 2008;121:1585-90.
10. Hemkens LG, Grouven U, Bender R, Günster C, Gutschmidt S, et al. Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study. Diabetologia 2009;52:1732-44.
11. Zhang P, Liu N, Wang Y. Insulin may cause deterioration of proliferative diabetic retinopathy. Med Hypotheses 2009;72: 306-8.
12. Martini LA, Wood RJ. Vitamin D status and the metabolic syndrome. Nutr Rev 2006;64:479-86. (Pubitemid 44808263)
13. Scragg R, Sowers M, Bell C. Serum 25-hydroxyvitamin D, diabetes, and ethnicity in the Third National Health and Nutrition Examination Survey. Diabetes Care 2004;27:2813-8. (Pubitemid 39565042)
14. Bell NH, Greene A, Epstein S, Oexmann MJ, Shaw S, et al. Evidence for alteration of the vitamin D-endocrine system in blacks. J Clin Invest 1985;76:470-3. (Pubitemid 15227507)
15. Pietschmann P, Schernthaner G, Woloszczuk W. Serum osteocal-cin levels in diabetes mellitus: analysis of the type of diabetes and microvascular complications. Diabetologia 1988;31:892-5. (Pubitemid 19054759)
16. Isaia G, Giorgino R, Adami S. High prevalence of hypovita-minosis D in female type 2 diabetic population. Diabetes Care 2001;24:1496.
17. Scragg R, Holdaway I, Singh V, Metcalf P, Baker J, et al. Serum 25-hydroxyvitamin D3 levels decreased in impaired glucose tolerance and diabetes mellitus. Diabetes Res Clin Pract 1995;27: 181-8.
18. Borissova AM, Tankova T, Kirilov G, Dakovska L, Kovacheva R. The effect of vitamin D3 on insulin secretion and peripheral insulin sensitivity in type 2 diabetic patients. Int J Clin Pract 2003;57:258-61. (Pubitemid 36700706)
19. Inomata S, Kadowaki S, Yamatani T, Fukase M, Fujita T. Effect of 1 alpha (OH)-vitamin D3 on insulin secretion in diabetes mellitus. Bone Miner 1986;1:187-92. (Pubitemid 16015701)
20. Kumar S, Davies M, Zakaria Y, Mawer EB, Gordon C, et al. Improvement in glucose tolerance and beta-cell function in a patient with vitamin D defi ciency during treatment with vitamin D. Postgrad Med 1994;70:440-3. (Pubitemid 24196871)
21. Schwalfenberg G. Vitamin D and diabetes. Can Fam Physician 2008;54:864-6.
22. Chiu KC, Chu A, Go VL, Saad MF. Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J Clin Nutr 2004;79:820-5. (Pubitemid 41103882)
23. Taylor WH, Khaleeli AA. Prevalence of primary hyperpara-thyroidism in patients with diabetes mellitus. Diabetes Med 1997;14:386-9. (Pubitemid 27248020)
24. Mak RH. Intravenous 1,25 dihydroxycholecalciferol corrects glucose intolerance in hemodialysis patients. Kidney Int 1992;41:1049-54.
25. Bener A, Alsaied A, Al-Ali M, Al-Kubaisi A, Basha B, et al. High prevalence of vitamin D defi ciency in type 1 diabetes mellitus and healthy children. Acta Diabetol 2009;46: 183-9.
26. Svoren BM, Volkening LK, Wood JR, Laffel LM. Signifi cant vitamin D defi ciency in youth with type 1 diabetes mellitus. J Pediatr 2009;154:132-4.
27. Baroncelli GI, Bereket A, El Kholy M, Aud i L, Cesur Y, et al. Rickets in the Middle East: role of environment and genetic predisposition. J Clin Endocrinol Metab 2008;93: 1743-50. (Pubitemid 351656513)